Cargando…
Rivaroxaban versus warfarin for the management of left ventricle thrombus
BACKGROUND: Rivaroxaban has been recently introduced for the management of non-valvular intra-cardiac thrombosis with variable results. We aimed to compare the results of the off-label use of rivaroxaban versus warfarin in the management of patients with left ventricle (LV) thrombus. This research i...
Autores principales: | Albabtain, Monirah A., Alhebaishi, Yahya, Al-Yafi, Ola, Kheirallah, Hatim, Othman, Adel, Alghosoon, Haneen, Arafat, Amr A., Alfagih, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088413/ https://www.ncbi.nlm.nih.gov/pubmed/33932172 http://dx.doi.org/10.1186/s43044-021-00164-7 |
Ejemplares similares
-
Assessment of the quality of anticoagulation management with warfarin in a tertiary care center
por: Albabtain, Monirah A., et al.
Publicado: (2020) -
Real-world Experience in Managing Atrial Fibrillation in Patients with Renal Impairment; Rivaroxaban versus Warfarin
por: Albabtain, Monirah Abdulrahman, et al.
Publicado: (2023) -
Long-Term Effects of Postoperative Atrial Fibrillation following Mitral Valve Surgery
por: Alghosoon, Haneen, et al.
Publicado: (2023) -
Comparison of Outcomes After Transcatheter Versus
Surgical Repeat Mitral Valve Replacement
por: Arafat, Amr A., et al.
Publicado: (2023) -
Better Survival in Morbidly Obese Patients with Atrial Fibrillation Treated with Non-vitamin K-dependent Oral Anticoagulants
por: Albabtain, Monirah A., et al.
Publicado: (2023)